{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:39:43Z","timestamp":1750307983256,"version":"3.41.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["WKJ-ZJ-2310"],"award-info":[{"award-number":["WKJ-ZJ-2310"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92474106"],"award-info":[{"award-number":["92474106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0520600"],"award-info":[{"award-number":["2024ZD0520600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02864-x","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T14:11:20Z","timestamp":1750255880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing causal associations between TNF-related apoptosis-inducing ligand, vascular endothelial growth factor and colon cancer: a Mendelian-randomization study"],"prefix":"10.1007","volume":"16","author":[{"given":"Chaoyang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"2864_CR1","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1002\/ijc.30382","volume":"139","author":"MM Fidler","year":"2016","unstructured":"Fidler MM, Soerjomataram I, Bray F. A global view on cancer incidence and National levels of the human development index. Int J Cancer. 2016;139:2436\u201346.","journal-title":"Int J Cancer"},{"key":"2864_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209\u201349.","journal-title":"Cancer J Clin"},{"key":"2864_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","volume":"16","author":"N Keum","year":"2019","unstructured":"Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16:713\u201332.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2864_CR4","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3748\/wjg.v22.i5.1745","volume":"22","author":"G Lech","year":"2016","unstructured":"Lech G, S\u0142otwi\u0144ski R, S\u0142odkowski M, Krasnod\u0119bski IW. Colorectal cancer tumour markers and biomarkers: recent therapeutic advances. World J Gastroenterol. 2016;22:1745\u201355.","journal-title":"World J Gastroenterol"},{"key":"2864_CR5","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1136\/gutjnl-2014-309086","volume":"64","author":"EH Schreuders","year":"2015","unstructured":"Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP, Kuipers EJ. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637\u201349.","journal-title":"Gut"},{"key":"2864_CR6","doi-asserted-by":"crossref","unstructured":"Wang H. MicroRNAs and apoptosis in colorectal Cancer. Int J Mol Sci. 2020;21:5353.","DOI":"10.3390\/ijms21155353"},{"key":"2864_CR7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s10555-018-9728-y","volume":"37","author":"X Yuan","year":"2018","unstructured":"Yuan X, Gajan A, Chu Q, Xiong H, Wu K, Wu GS. Developing TRAIL\/TRAIL death receptor-based cancer therapies. Cancer Metastasis Rev. 2018;37:733\u201348.","journal-title":"Cancer Metastasis Rev"},{"key":"2864_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2009.02.029","volume":"285","author":"GS Wu","year":"2009","unstructured":"Wu GS. TRAIL as a target in anti-cancer therapy. Cancer Lett. 2009;285:1\u20135.","journal-title":"Cancer Lett"},{"key":"2864_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/path.2797","volume":"223","author":"DM Heijink","year":"2011","unstructured":"Heijink DM, Jalving M, Oosterhuis D, Sloots IA, Koster R, Hollema H, Kleibeuker JH, Koornstra JJ, de Vries EG, de Jong S. TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells. J Pathol. 2011;223:378\u201389.","journal-title":"J Pathol"},{"key":"2864_CR10","first-page":"41","volume":"17","author":"H Gong","year":"2019","unstructured":"Gong H, Cheng W, Wang Y. Tumor necrosis factor-related apoptosis-inducing ligand inhibits the growth and aggressiveness of colon carcinoma via the exogenous apoptosis signaling pathway. Experimental Therapeutic Med. 2019;17:41\u201350.","journal-title":"Experimental Therapeutic Med"},{"key":"2864_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.surg.2005.05.012","volume":"138","author":"PG Rychahou","year":"2005","unstructured":"Rychahou PG, Murillo CA, Evers BM. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL). Surgery. 2005;138:391\u20137.","journal-title":"Surgery"},{"key":"2864_CR12","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s10495-016-1287-5","volume":"21","author":"L Chen","year":"2016","unstructured":"Chen L, Meng Y, Guo X, Sheng X, Tai G, Zhang F, Cheng H, Zhou Y. Gefitinib enhances human colon cancer cells to TRAIL-induced apoptosis of via autophagy- and JNK-mediated death receptors upregulation. Apoptosis: Int J Program Cell Death. 2016;21:1291\u2013301.","journal-title":"Apoptosis: Int J Program Cell Death"},{"key":"2864_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/sj.cdd.4401919","volume":"14","author":"AC Williams","year":"2007","unstructured":"Williams AC, Smartt H, AM HZ, Macfarlane M, Paraskeva C, Collard TJ. Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through Inhibition of NF-kappaB. Cell Death Differ. 2007;14:137\u201345.","journal-title":"Cell Death Differ"},{"key":"2864_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrc.2017.28","volume":"17","author":"S von Karstedt","year":"2017","unstructured":"von Karstedt S, Montinaro A, Walczak H. Exploring the trails less travelled: TRAIL in cancer biology and therapy. Nat Rev Cancer. 2017;17:352\u201366.","journal-title":"Nat Rev Cancer"},{"key":"2864_CR15","doi-asserted-by":"crossref","unstructured":"Diaz Arguello OA, Haisma HJ. Apoptosis-Inducing TNF superfamily ligands for Cancer therapy. Cancers 13 (2021).","DOI":"10.3390\/cancers13071543"},{"key":"2864_CR16","doi-asserted-by":"crossref","unstructured":"Semba M, Takamatsu S, Komazawa-Sakon S, Miyoshi E, Nishiyama C, Nakano H. and K. Moriwaki, proscillaridin A sensitizes human Colon cancer cells to TRAIL-Induced cell death. Int J Mol Sci 23 (2022).","DOI":"10.3390\/ijms23136973"},{"key":"2864_CR17","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019;176:1248\u201364.","journal-title":"Cell"},{"key":"2864_CR18","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/NEJMra0706596","volume":"358","author":"RS Kerbel","year":"2008","unstructured":"Kerbel RS. Tumor angiogenesis. N Engl J Med. 2008;358:2039\u201349.","journal-title":"N Engl J Med"},{"key":"2864_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"D Fukumura","year":"2018","unstructured":"Fukumura D, Kloepper J, Amoozgar Z, Duda DG, Jain RK. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nature Rev Clin Oncol. 2018;15:325\u201340.","journal-title":"Nat Rev Clin Oncol"},{"key":"2864_CR20","doi-asserted-by":"publisher","first-page":"1616370","DOI":"10.1155\/2022\/1616370","volume":"2022","author":"Q Song","year":"2022","unstructured":"Song Q, Gao J, Yang J, Gopinath SCB, Shen L. Prognostic analysis of LncRNA MCM3AP-AS1 in colorectal Cancer and the mechanism of its effect on tumor cell activity. Biomed Res Int. 2022;2022:1616370.","journal-title":"Biomed Res Int"},{"key":"2864_CR21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41416-021-01681-7","volume":"126","author":"S Guo","year":"2022","unstructured":"Guo S, Li J, Huang Z, Yue T, Zhu J, Wang X, Liu Y, Wang P, Chen S. The CBS-H(2)S axis promotes liver metastasis of colon cancer by upregulating VEGF through AP-1 activation. Br J Cancer. 2022;126:1055\u201366.","journal-title":"Br J Cancer"},{"key":"2864_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2020.04.021","volume":"488","author":"S Yan","year":"2020","unstructured":"Yan S, Wang H, Chen X, Liang C, Shang W, Wang L, Li J, Xu D. MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C. Cancer Lett. 2020;488:18\u201326.","journal-title":"Cancer Lett"},{"key":"2864_CR23","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.omtn.2019.10.012","volume":"18","author":"X Li","year":"2019","unstructured":"Li X, Lv X, Li Z, Li C, Li X, Xiao J, Liu B, Yang H, Zhang Y. Long noncoding RNA ASLNC07322 functions in VEGF-C expression regulated by Smad4 during Colon cancer metastasis. Molecular therapy. Nucleic Acids. 2019;18:851\u201362.","journal-title":"Nucleic Acids"},{"key":"2864_CR24","doi-asserted-by":"crossref","unstructured":"Bakshi HA, Quinn GA, Nasef MM, Mishra V, Aljabali AAA, El-Tanani M, Serrano-Aroca \u00c1, Webba M, Da Silva PA, McCarron, Tambuwala MM. Crocin inhibits angiogenesis and metastasis in Colon cancer via TNF-\u03b1\/NF-kB\/VEGF pathways. Cells. 2022;11:1502.","DOI":"10.3390\/cells11091502"},{"key":"2864_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10456-013-9387-0","volume":"17","author":"HJ Na","year":"2014","unstructured":"Na HJ, Hwang JY, Lee KS, Choi YK, Choe J, Kim JY, Moon HE, Kim KW, Koh GY, Lee H, Jeoung D, Won MH, Ha KS, Kwon YG, Kim YM. TRAIL negatively regulates VEGF-induced angiogenesis via caspase-8-mediated enzymatic and non-enzymatic functions. Angiogenesis. 2014;17:179\u201394.","journal-title":"Angiogenesis"},{"key":"2864_CR26","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/sj.bjc.6603092","volume":"94","author":"G Cantarella","year":"2006","unstructured":"Cantarella G, Risuglia N, Dell\u2019eva R, Lempereur L, Albini A, Pennisi G, Scoto GM, Noonan DN, Bernardini R. TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells. Br J Cancer. 2006;94:1428\u201335.","journal-title":"Br J Cancer"},{"key":"2864_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S. Mendelian randomization\u2019: can genetic epidemiology contribute to Understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1\u201322.","journal-title":"Int J Epidemiol"},{"key":"2864_CR28","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JA, Timpson N. Davey smith, Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27:1133\u201363.","journal-title":"Stat Med"},{"key":"2864_CR29","doi-asserted-by":"crossref","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318:1925\u20136.","DOI":"10.1001\/jama.2017.17219"},{"key":"2864_CR30","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658\u201365.","journal-title":"Genet Epidemiol"},{"key":"2864_CR31","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23:R89\u201398.","journal-title":"Hum Mol Genet"},{"key":"2864_CR32","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/S2214-109X(13)70113-X","volume":"1","author":"RR Bourne","year":"2013","unstructured":"Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Resnikoff S, Taylor HR. Causes of vision loss worldwide, 1990\u20132010: a systematic analysis. Lancet Global Health. 2013;1:e339\u201349.","journal-title":"Lancet Global Health"},{"key":"2864_CR33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755\u201364.","journal-title":"Int J Epidemiol"},{"key":"2864_CR34","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40:740\u201352.","journal-title":"Int J Epidemiol"},{"key":"2864_CR35","first-page":"n2233","volume":"375","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, Timpson NJ, Higgins JPT, Dimou N, Langenberg C, Loder EW, Golub RM, Egger M, Davey Smith G, Richards JB. Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ (Clinical Res ed). 2021;375:n2233.","journal-title":"BMJ (Clinical Res ed)"},{"key":"2864_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/jamapsychiatry.2020.3554","volume":"78","author":"DB Rosoff","year":"2021","unstructured":"Rosoff DB, Smith GD, Lohoff FW. Prescription opioid use and risk for major depressive disorder and anxiety and stress-related disorders: a multivariable Mendelian randomization analysis. JAMA Psychiatry. 2021;78:151\u201360.","journal-title":"JAMA Psychiatry"},{"key":"2864_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1053\/j.ajkd.2021.04.018","volume":"79","author":"S Yuan","year":"2022","unstructured":"Yuan S, Larsson SC. Coffee and caffeine consumption and risk of kidney stones: a Mendelian randomization study. Am J Kidney Dis. 2022;79:9\u2013e141.","journal-title":"Am J Kidney Dis"},{"key":"2864_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s12967-022-03648-5","volume":"20","author":"J Cai","year":"2022","unstructured":"Cai J, Li X, Wu S, Tian Y, Zhang Y, Wei Z, Jin Z, Li X, Chen X, Chen WX. Assessing the causal association between human blood metabolites and the risk of epilepsy. J Transl Med. 2022;20:437.","journal-title":"J Transl Med"},{"key":"2864_CR39","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/jamapsychiatry.2018.4175","volume":"76","author":"KW Choi","year":"2019","unstructured":"Choi KW, Chen CY, Stein MB, Klimentidis YC, Wang MJ, Koenen KC, Smoller JW. Assessment of bidirectional relationships between physical activity and depression among adults: a 2-sample Mendelian randomization study. JAMA Psychiatry. 2019;76:399\u2013408.","journal-title":"JAMA Psychiatry"},{"key":"2864_CR40","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512\u201325.","journal-title":"Int J Epidemiol"},{"key":"2864_CR41","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304\u201314.","journal-title":"Genet Epidemiol"},{"key":"2864_CR42","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal Pleiotropy assumption. Int J Epidemiol. 2017;46:1985\u201398.","journal-title":"Int J Epidemiol"},{"key":"2864_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32:377\u201389.","journal-title":"Eur J Epidemiol"},{"key":"2864_CR44","doi-asserted-by":"crossref","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, Tan VY, Yarmolinsky J, Shihab HA, Timpson NJ, Evans DM, Relton C, Martin RM, Davey Smith G, Gaunt TR, Haycock PC. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7:e34408","DOI":"10.7554\/eLife.34408"},{"key":"2864_CR45","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.1111\/febs.15637","volume":"288","author":"L Cardoso Alves","year":"2021","unstructured":"Cardoso Alves L, Corazza N, Micheau O, Krebs P. The multifaceted role of TRAIL signaling in cancer and immunity. FEBS J. 2021;288:5530\u201354.","journal-title":"FEBS J"},{"key":"2864_CR46","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1002\/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B","volume":"31","author":"K Sato","year":"2001","unstructured":"Sato K, Hida S, Takayanagi H, Yokochi T, Kayagaki N, Takeda K, Yagita H, Okumura K, Tanaka N, Taniguchi T, Ogasawara K. Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha\/beta. Eur J Immunol. 2001;31:3138\u201346.","journal-title":"Eur J Immunol"},{"key":"2864_CR47","doi-asserted-by":"crossref","unstructured":"Ahlenstiel G, Titerence RH, Koh C, Edlich B, Feld JJ, Rotman Y, Ghany MG, Hoofnagle JH, Liang TJ, Heller T, Rehermann B. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology. 2010;138: 325\u2009\u2013\u200935.e1-2.","DOI":"10.1053\/j.gastro.2009.08.066"},{"key":"2864_CR48","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.4049\/jimmunol.181.7.4918","volume":"181","author":"EL Brincks","year":"2008","unstructured":"Brincks EL, Katewa A, Kucaba TA, Griffith TS, Legge KL. CD8 T cells utilize TRAIL to control influenza virus infection. J Immunol (Baltimore Md : 1950). 2008;181:4918\u201325.","journal-title":"J Immunol (Baltimore Md : 1950)"},{"key":"2864_CR49","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1084\/jem.20120983","volume":"209","author":"K Steinwede","year":"2012","unstructured":"Steinwede K, Henken S, Bohling J, Maus R, Ueberberg B, Brumshagen C, Brincks EL, Griffith TS, Welte T, Maus UA. TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of Pneumococcal pneumonia in mice. J Exp Med. 2012;209:1937\u201352.","journal-title":"J Exp Med"},{"key":"2864_CR50","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1084\/jem.189.8.1343","volume":"189","author":"TS Griffith","year":"1999","unstructured":"Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR, Fanger NA. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J Exp Med. 1999;189:1343\u201354.","journal-title":"J Exp Med"},{"key":"2864_CR51","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.4049\/jimmunol.161.5.2195","volume":"161","author":"WD Thomas","year":"1998","unstructured":"Thomas WD, Hersey P. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J Immunol (Baltimore Md : 1950). 1998;161:2195\u2013200.","journal-title":"J Immunol (Baltimore Md : 1950)"},{"key":"2864_CR52","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1006\/cimm.2001.1896","volume":"214","author":"K Takeda","year":"2001","unstructured":"Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Yamaguchi N, Yagita H, Okumura K. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth. Cell Immunol. 2001;214:194\u2013200.","journal-title":"Cell Immunol"},{"key":"2864_CR53","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000324400","volume":"3","author":"J Villard","year":"2011","unstructured":"Villard J. The role of natural killer cells in human solid organ and tissue transplantation. J Innate Immun. 2011;3:395\u2013402.","journal-title":"J Innate Immun"},{"key":"2864_CR54","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1600-0609.2007.00834.x","volume":"78","author":"H Tanaka","year":"2007","unstructured":"Tanaka H, Ito T, Kyo T, Kimura A. Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients. Eur J Haematol. 2007;78:389\u201398.","journal-title":"Eur J Haematol"},{"key":"2864_CR55","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1084\/jem.190.8.1155","volume":"190","author":"NA Fanger","year":"1999","unstructured":"Fanger NA, Maliszewski CR, Schooley K, Griffith TS. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Exp Med. 1999;190:1155\u201364.","journal-title":"J Exp Med"},{"key":"2864_CR56","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.4049\/jimmunol.1102437","volume":"188","author":"ML Kalb","year":"2012","unstructured":"Kalb ML, Glaser A, Stary G, Koszik F, Stingl G. TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-\u03b1-mediated antitumor reactivity. J Immunol (Baltimore Md : 1950). 2012;188:1583\u201391.","journal-title":"J Immunol (Baltimore Md : 1950)"},{"key":"2864_CR57","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1053\/j.gastro.2010.01.051","volume":"138","author":"KA Stegmann","year":"2010","unstructured":"Stegmann KA, Bj\u00f6rkstr\u00f6m NK, Veber H, Ciesek S, Riese P, Wiegand J, Hadem J, Suneetha PV, Jaroszewicz J, Wang C, Schlaphoff V, Fytili P, Cornberg M, Manns MP, Geffers R, Pietschmann T, Guzm\u00e1n CA, Ljunggren HG, Wedemeyer H. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology. 2010;138:1885\u201397.","journal-title":"Gastroenterology"},{"key":"2864_CR58","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1084\/jem.189.9.1451","volume":"189","author":"N Kayagaki","year":"1999","unstructured":"Kayagaki N, Yamaguchi N, Nakayama M, Eto H, Okumura K, Yagita H. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs. J Exp Med. 1999;189:1451\u201360.","journal-title":"J Exp Med"},{"key":"2864_CR59","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1182\/blood-2003-08-2806","volume":"103","author":"C Tecchio","year":"2004","unstructured":"Tecchio C, Huber V, Scapini P, Calzetti F, Margotto D, Todeschini G, Pilla L, Martinelli G, Pizzolo G, Rivoltini L, Cassatella MA. IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL\/Apo-2 ligand) displaying apoptotic activity on leukemic cells. Blood. 2004;103:3837\u201344.","journal-title":"Blood"},{"key":"2864_CR60","doi-asserted-by":"publisher","first-page":"892","DOI":"10.4049\/jimmunol.173.2.892","volume":"173","author":"TJ Kemp","year":"2004","unstructured":"Kemp TJ, Moore JM, Griffith TS. Human B cells express functional TRAIL\/Apo-2 ligand after CpG-containing oligodeoxynucleotide stimulation. J Immunol (Baltimore Md : 1950). 2004;173:892\u20139.","journal-title":"J Immunol (Baltimore Md : 1950)"},{"key":"2864_CR61","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.4049\/jimmunol.167.7.3765","volume":"167","author":"PO Vidalain","year":"2001","unstructured":"Vidalain PO, Azocar O, Yagita H, Rabourdin-Combe C, Servet-Delprat C. Cytotoxic activity of human dendritic cells is differentially regulated by double-stranded RNA and CD40 ligand. J Immunol (Baltimore Md : 1950). 2001;167:3765\u201372.","journal-title":"J Immunol (Baltimore Md : 1950)"},{"issue":"2006","key":"2864_CR62","first-page":"248","volume":"176","author":"L Chaperot","year":"1950","unstructured":"Chaperot L, Blum A, Manches O, Lui G, Angel J, Molens JP, Plumas J. Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J Immunol (Baltimore Md. 1950;176(2006):248\u201355.","journal-title":"J Immunol (Baltimore Md"},{"key":"2864_CR63","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.0019-2805.2003.01794.x","volume":"111","author":"H Kamohara","year":"2004","unstructured":"Kamohara H, Matsuyama W, Shimozato O, Abe K, Galligan C, Hashimoto S, Matsushima K, Yoshimura T. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils. Immunology. 2004;111:186\u201394.","journal-title":"Immunology"},{"key":"2864_CR64","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1084\/jem.193.6.661","volume":"193","author":"MJ Smyth","year":"2001","unstructured":"Smyth MJ, Cretney E, Takeda K, Wiltrout RH, Sedger LM, Kayagaki N, Yagita H, Okumura K. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med. 2001;193:661\u201370.","journal-title":"J Exp Med"},{"key":"2864_CR65","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1172\/JCI6926","volume":"104","author":"A Ashkenazi","year":"1999","unstructured":"Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Investig. 1999;104:155\u201362.","journal-title":"J Clin Investig"},{"key":"2864_CR66","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/5517","volume":"5","author":"H Walczak","year":"1999","unstructured":"Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med. 1999;5:157\u201363.","journal-title":"Nat Med"},{"key":"2864_CR67","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ccell.2015.02.014","volume":"27","author":"S von Karstedt","year":"2015","unstructured":"von Karstedt S, Conti A, Nobis M, Montinaro A, Hartwig T, Lemke J, Legler K, Annewanter F, Campbell AD, Taraborrelli L, Grosse-Wilde A, Coy JF, El-Bahrawy MA, Bergmann F, Koschny R, Werner J, Ganten TM, Schweiger T, Hoetzenecker K, Kenessey I, Heged\u00fcs B, Bergmann M, Hauser C, Egberts JH, Becker T, R\u00f6cken C, Kalthoff H, Trauzold A, Anderson KI, Sansom OJ, Walczak H. Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis. Cancer Cell. 2015;27:561\u201373.","journal-title":"Cancer Cell"},{"key":"2864_CR68","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.molcel.2017.01.021","volume":"65","author":"T Hartwig","year":"2017","unstructured":"Hartwig T, Montinaro A, von Karstedt S, Sevko A, Surinova S, Chakravarthy A, Taraborrelli L, Draber P, Lafont E, Arce Vargas F, El-Bahrawy MA, Quezada SA, Walczak H. The TRAIL-Induced Cancer secretome promotes a Tumor-Supportive immune microenvironment via CCR2. Mol Cell. 2017;65:730\u2013e7425.","journal-title":"Mol Cell"},{"key":"2864_CR69","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.molcel.2017.01.022","volume":"65","author":"CM Henry","year":"2017","unstructured":"Henry CM, Martin SJ. Caspase-8 acts in a non-enzymatic role as a scaffold for assembly of a pro-inflammatory faddosome complex upon TRAIL stimulation. Mol Cell. 2017;65:715\u2013e7295.","journal-title":"Mol Cell"},{"key":"2864_CR70","doi-asserted-by":"crossref","unstructured":"Dilshara MG, Molagoda IMN, Jayasooriya R, Choi YH, Park C, Lee KT, Lee S, Kim GY. p53-mediated oxidative stress enhances Iindirubin-3\u2019-monoxime-induced apoptosis in HCT116 colon cancer cells by upregulating death receptor 5 and TNF-related apoptosis-inducing ligand expression. Antioxid (Basel Switzerland) 8 (2019).","DOI":"10.20944\/preprints201908.0182.v1"},{"key":"2864_CR71","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ijbiomac.2018.11.200","volume":"124","author":"LC Yang","year":"2019","unstructured":"Yang LC, Lai CY, Hsieh CC, Lin WC. Natural killer cell-mediated anticancer effects of an Arabinogalactan derived from rice hull in CT26 colon cancer-bearing mice. Int J Biol Macromol. 2019;124:368\u201376.","journal-title":"Int J Biol Macromol"},{"key":"2864_CR72","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1038\/s41598-022-09660-5","volume":"12","author":"S Lotfollahzadeh","year":"2022","unstructured":"Lotfollahzadeh S, Hosseini ES, Mahmoudi Aznaveh H, Nikkhah M, Hosseinkhani S. TRAIL\/S-layer\/graphene quantum Dot nanohybrid enhanced stability and anticancer activity of TRAIL on colon cancer cells. Sci Rep. 2022;12:5851.","journal-title":"Sci Rep"},{"key":"2864_CR73","doi-asserted-by":"crossref","unstructured":"Malki A, ElRuz RA, Gupta I, Allouch A, Vranic S, Al moustafa AE. Molecular mechanisms of colon cancer progression and metastasis: recent insights and advancements. Int J Mol Sci. 2020;22:130.","DOI":"10.3390\/ijms22010130"},{"key":"2864_CR74","doi-asserted-by":"crossref","unstructured":"Lopez A, Harada K, Vasilakopoulou M, Shanbhag N, Ajani JA. Target angiogenesis colorectal carcinoma drugs. 2019;79:63\u201374.","DOI":"10.1007\/s40265-018-1037-9"},{"key":"2864_CR75","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2407-12-58","volume":"12","author":"A Bisgin","year":"2012","unstructured":"Bisgin A, Kargi A, Yalcin AD, Aydin C, Ekinci D, Savas B, Sanlioglu S. Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer. BMC Cancer. 2012;12:58.","journal-title":"BMC Cancer"},{"key":"2864_CR76","doi-asserted-by":"publisher","first-page":"e15627","DOI":"10.1371\/journal.pone.0015627","volume":"5","author":"S Ganapathy","year":"2010","unstructured":"Ganapathy S, Chen Q, Singh KP, Shankar S, Srivastava RK. Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor. PLoS ONE. 2010;5:e15627.","journal-title":"PLoS ONE"},{"key":"2864_CR77","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/sj.ki.5002354","volume":"72","author":"VS Stel","year":"2007","unstructured":"Stel VS, Jager KJ, Zoccali C, Wanner C, Dekker FW. The randomized clinical trial: an unbeatable standard in clinical research? Kidney Int. 2007;72:539\u201342.","journal-title":"Kidney Int"},{"key":"2864_CR78","doi-asserted-by":"crossref","unstructured":"Linsel-Nitschke P, G\u00f6tz A, Erdmann J, Braenne I, Braund P, Hengstenberg C, Stark K, Fischer M, Schreiber S, El Mokhtari N.E., Schaefer A, Schrezenmeir J, Rubin D, Hinney A, Reinehr T, Roth C, Ortlepp J, Hanrath P, Hall A.S., Mangino M., Lieb W., Lamina C., Heid I.M., Doering A., Gieger C., Peters A., Meitinger T., Wichmann H.E., K\u00f6nig I.R., Ziegler A., Kronenberg F., Samani N.J., Schunkert H. Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease\u2013a Mendelian randomisation study. PLoS ONE. 2008;3:e2986.","DOI":"10.1371\/journal.pone.0002986"},{"key":"2864_CR79","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11864-015-0333-9","volume":"16","author":"K Papadimitriou","year":"2015","unstructured":"Papadimitriou K, Rolfo C, Dewaele E, Van De Wiel M, Van den Brande J, Altintas S, Huizing M, Specenier P, Peeters M. Incorporating anti-VEGF pathway therapy as a continuum of care in metastatic colorectal cancer. Curr Treat Options Oncol. 2015;16:18.","journal-title":"Curr Treat Options Oncol"},{"key":"2864_CR80","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41569-020-00493-1","volume":"18","author":"MV Holmes","year":"2021","unstructured":"Holmes MV, Richardson TG, Ference BA, Davies NM. Davey smith, integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development. Nat Rev Cardiol. 2021;18:435\u201353.","journal-title":"Nat Rev Cardiol"},{"key":"2864_CR81","first-page":"e50","volume":"383","author":"H H\u00f3lm","year":"2020","unstructured":"H\u00f3lm H, Sulem P, Helgad\u00f3ttir A, Tragante V, \u00deorleifsson G, Gu\u00f0bjartsson D, Stef\u00e1nsson K. Mendelian randomization study of ACLY and cardiovascular disease. N Engl J Med. 2020;383:e50.","journal-title":"N Engl J Med"},{"key":"2864_CR82","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S2213-2600(20)30364-7","volume":"9","author":"A Duckworth","year":"2021","unstructured":"Duckworth A, Gibbons MA, Allen RJ, Almond H, Beaumont RN, Wood AR, Lunnon K, Lindsay MA, Wain LV, Tyrrell J, Scotton CJ. Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a Mendelian randomisation study. Lancet Respiratory Med. 2021;9:285\u201394.","journal-title":"Lancet Respiratory Med"},{"key":"2864_CR83","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","volume":"30","author":"S Burgess","year":"2015","unstructured":"Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30:543\u201352.","journal-title":"Eur J Epidemiol"},{"key":"2864_CR84","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/gepi.21998","volume":"40","author":"S Burgess","year":"2016","unstructured":"Burgess S, Davies NM, Thompson SG. Bias due to participant overlap in two-sample Mendelian randomization. Genet Epidemiol. 2016;40:597\u2013608.","journal-title":"Genet Epidemiol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02864-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02864-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02864-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T15:02:31Z","timestamp":1750258951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02864-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2864"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02864-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical review and approval of this study were waived, as the data supporting these results were obtained from the IEU Open GWAS database (), which were publicly accessible and deidentified.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1146"}}